Congratulations to our 3rd-year #BrighamGIFellow Dr. Saeed Soleymanjahi @SaeedJahi for receiving the American Pancreatic Association Young Investigator Award! We're so proud of you and your work!
#BWHPancreas
Less than one week from our first MGB Cancer Institute Pancreatic Cancer Symposium! Hear thought leaders, latest research, and patients discuss progress and innovation at MGB. Registration free! @motazqadan@MassGenBrigham@PanCAN@aberkenblit@ZhiVenFongMD.
It takes decades to build the momentum in science — now is the time — at the pioneering edge of almost every scientific field — to sustain it!! @MGBResearchNews#NumberOne 🧠 🔬 🧫 🧬
https://t.co/4cs1H1T8vL
We are excited to announce the inaugural Mass General Brigham Cancer Instititute Pancreatic Cancer Symposium on Nov 18. We will highlight some of the most innovative work in this disease happening across our system. Honored to have keynote lecture by Dr Liz Jaffee.
Check out Thomas Clancy's fundraising page - https://t.co/EiPHGS6dpk
Last push before BAA 10K to support our hepatopancreatobiliary program at Mass General Brigham Cancer Institute
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
Absolutely practice changing!! One of the most stunning developments in the treatment of patients with metastatic pancreatic cancer !! It is one of the rare moments in oncology which you will always remember ! Like the imatinib, trastuzumab presentations @ASCO#ASCO26@OncoAlert
I hope you didn’t miss out on @paul_wongg talk at #AHPBA26 on an externalized pancreatic stent during robotic Whipple!! Looking forward to the manuscript! 💫
@TClancyMD told me in November, two weeks post Whipple that I would enjoy a walk on the beach in March and not feel the effects of the surgery.
I doubted him.
Today I took that walk and he was right. I didn’t feel the effects of the surgery.
I even stopped to capture an image of the moment.
Praise God and thank you Dr. Clancy.
Looking forward to a new position as Director of Interventional Cardiology at Mass General Brigham. With incredible colleagues throughout the system, we will build the most comprehensive IC program internationally.